Lilly’s Cassell joins PhRMA bioterror team
Executive Summary
Lilly VP-Scientific Affairs Gail Cassell, PhD, joins the Pharmaceutical Research & Manufacturers of America on "part-time basis to work on the industry's biomedical preparedness issues." Cassell will "help to develop a long-term strategy for research on infectious diseases"...
You may also be interested in...
HHS Bioterror Research Oversight Preserved By Commerce Cmte. DHS Plan
HHS would retain authority over drug research related to bioterrorism under the House Energy & Commerce Committee mark of the "Homeland Security Act" (HR 5005) completed July 11
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.